ABVC
ABVC BioPharma·NASDAQ
--
--(--)
--
--(--)
ABVC Filings
Filing Date
Form Description
Form Type
2026-03-05
Form DEF 14A - Other definitive proxy statements
Key Events
2026-03-05 · Key Events
Form DEF 14A - Other definitive proxy statements
2026-03-03
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Financials
2026-03-03 · Financials
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2026-03-03
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-03-03 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-03-03
Form 8-K - Current report
Key Events
2026-03-03 · Key Events
Form 8-K - Current report
2026-02-05
Form PRE 14A - Other preliminary proxy statements
Key Events
2026-02-05 · Key Events
Form PRE 14A - Other preliminary proxy statements
2026-01-16
Form 8-K/A - Current report: [Amend]
Key Events
2026-01-16 · Key Events
Form 8-K/A - Current report: [Amend]
2025-11-14
Form 424B4 - Prospectus [Rule 424(b)(4)]
2025-11-14 ·
Form 424B4 - Prospectus [Rule 424(b)(4)]
2025-11-14
Form 424B4 - Prospectus [Rule 424(b)(4)]
2025-11-14 ·
Form 424B4 - Prospectus [Rule 424(b)(4)]
2025-11-14
Form 424B4 - Prospectus [Rule 424(b)(4)]
2025-11-14 ·
Form 424B4 - Prospectus [Rule 424(b)(4)]
2025-11-14
Form 424B4 - Prospectus [Rule 424(b)(4)]
2025-11-14 ·
Form 424B4 - Prospectus [Rule 424(b)(4)]
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
